Clinical Trial Update: 18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma [Phase 1]

View source ↗

Summary

A terminated Phase 1 trial from Stanford evaluated the PET imaging tracer 18F-F-AraG to assess immunological response to CAR T cell therapy in non-Hodgkin lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• [18F]F-AraG

Snippet

Sponsor: Stanford University | Conditions: Non-Hodgkin's Lymphoma | Phase 1 | Status: TERMINATED